GCV - Gabelli Convertible & Income Securities Fund

A closed-end fund run by Gabelli. Invests in convertible bonds. Listed on the New York Stock Exchange.

Is anyone targeting this fund?

No - none of the investors we follow has reported owning 5% or more of this fund.

See the investors we follow

Is the fund doing anything you need to act on?

Nothing right now.

What this means for you

None of the investors we follow has reported owning 5% or more of this fund. That is the normal state for most closed-end funds.

Nothing is required of you. If that changes, the notice appears here within a day of being filed with the regulator.

Email me if this changes

What happened, and when

  1. May 27, 2025

    The fund said it will repay some borrowed money on June 26, 2025.

    Original document →

About this fund

+65%-3%
July 2024June 2026
Value of the holdings, month by month, from July 2024 to June 2026: up 61.8% in all, before the share price is taken into account. The grey line is where it started.

How this has changed

What these lines mean: a payout that is your own money back, what a fund costs, borrowing.

What a holder made

Why the shares and the holdings can differ: the gap between price and value. Why payouts count: a payout that is your own money back.

What the fund holds

Mostly bonds (86%), the rest preferred shares and shares. About 83% issued in the U.S.

  1. Nebius Group NV - 4.7%
  2. Hewlett Packard Enterprise Company 7.625% Series C Mandatory Convertible Preferred Stock - 3.1%
  3. Fluor, Flr 1.125 08/15/29 - 2.8%
  4. Cyberark Software, Cybr 0 06/15/30 - 2.6%
  5. Bitfarms, Keel 1.375 01/15/31 - 2.4%
  6. Cytokinetics, Cytk 1.75 10/01/31 - 2.3%
  7. Firstenergy, Fe 3.875 01/15/31 - 2.3%
  8. Ligand Pharmaceuticals, Lgnd 0.75 10/01/30 - 2.2%
  9. Bridgebio Pharma, Bbio 1.75 03/01/31 - 2.1%
  10. Nextera Energy, Nee 7.234 11/01/27 - 2.1%
Show all 24
  1. Halozyme Therapeutics, Halo 0.875 11/15/32 - 1.9%
  2. Ionis Pharmaceuticals, Ions 0 12/01/30 - 1.9%
  3. Microchip Technology Inc 7.50 % Dep Shs Repstg 1/20TH Pfd Conv preferred shares - 1.8%
  4. Digital Realty Trust L.P., Dlr 1.875 11/15/29 - 1.8%
  5. Sarepta Therapeutics, Srpt 4.875 09/01/30 144A - 1.7%
  6. Ppl Capital Funding, Ppl 2.875 03/15/28 - 1.7%
  7. Alphabet Inc Series A Depositary Shares Each Representing A 1/20TH Interest in A Share of 6.25% Series B Mandatory Convertible Preferred Stock - 1.6%
  8. Adtran Holdings, Adtn 3.75 09/15/30 - 1.6%
  9. Cohu 1.5 01/15/31 - 1.6%
  10. United States of America - Bureau of the Public Debt, B 0 09/24/26 - 1.6%
  11. Crescent Energy Company, Crgy 2.75 03/15/31 - 1.5%
  12. Energy Fuels, Efrcn 0.75 11/01/31 - 1.5%
  13. Ani Pharmaceuticals, Anip 2.25 09/01/29 - 1.4%
  14. Mp Materials, Mpus 3 03/01/30 - 1.4%

As of June 30, 2026, from the fund's quarterly holdings report. Original document →

Details: all notices, events and fund facts

No notices from large investors on file.

What the fund announced
DateWhatDeadlineDocument
May 27, 2025 Repaying borrowed money June 26, 2025 Original document →
Run by
Gabelli Funds, LLC
Fund family
Gabelli Fund Complex
Exchange
New York Stock Exchange
Regulator's file number
811-05715
Auditor
Tait, Weller & Baker LLP
Fiscal year end
Sept 30, 2025
Number of holdings
121
Preferred share classes
1

See this fund's page at the SEC →

Download this fund's history (CSV)

Follow this fund in a news reader (feed)

Email me when something new is filed for GCV

Free. One email when a large investor files a notice, or when the fund announces a buy-back, a vote or a closing - usually within a day. No password. Most funds announce payout changes on their own website, where we do not look.